9KC:F:F-MARUSAN SEC. (EUR)

COMMON STOCK | Capital Markets |

Last Closing

USD 5.9

Change

+0.10 (+1.72)%

Market Cap

USD 0.37B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-12 )

Largest Industry Peers for Capital Markets

Symbol Name Price(Change) Market Cap
DWD:F Morgan Stanley

+2.38 (+1.91%)

USD 173.77B
GOS0:F GOLDMANN SACHS GROUP CDR

-0.40 (-2.05%)

USD 170.29B
GOS:F The Goldman Sachs Group Inc

+8.30 (+1.48%)

USD 151.17B
SWG:F The Charles Schwab Corporation

-0.87 (-1.18%)

USD 119.23B
4M4:F Macquarie Group Limited

-3.26 (-2.30%)

USD 53.81B
CI9:F CITIC Securities Company Limit..

+0.04 (+1.43%)

USD 49.49B
4T0:F Tradeweb Markets Inc

N/A

USD 26.30B
195H:F China Merchants Securities Co...

-0.01 (-0.53%)

USD 23.12B
153A:F GUOTAI JUNAN SEC. H YC1

N/A

USD 22.54B
206G:F HUATEI SECS.CO GDR S/10

N/A

USD 18.89B

ETFs Containing 9KC:F

TRVL:CA Harvest Travel & Leisure .. 9.42 % 0.00 %

+0.18 (+0%)

CAD 0.07B
TRVL-U:CA Harvest Travel & Leisure .. 9.42 % 0.00 %

+1.32 (+0%)

N/A
TRYP 4.71 % 0.00 %

N/A

N/A
XMID:LSE Xtrackers MSCI Indonesia .. 4.63 % 0.00 %

+0.25 (+0%)

N/A
XIDD:LSE Xtrackers MSCI Indonesia .. 4.63 % 0.00 %

-0.03 (0%)

N/A
LSAT Two Roads Shared Trust - .. 3.55 % 0.00 %

+0.01 (+0%)

USD 0.12B
PKW Invesco BuyBack Achievers.. 2.49 % 0.62 %

+0.01 (+0%)

USD 1.22B
GENE:LSE UBS (Irl) ETF Public Limi.. 1.12 % 0.00 %

+1.80 (+0%)

N/A
GENG:LSE UBS (Irl) ETF plc - Globa.. 1.12 % 0.00 %

-4.25 (0%)

USD 3.61M
RCD Invesco S&P 500® Equal W.. 0.00 % 0.40 %

N/A

N/A
XLDX:LSE Xtrackers LevDAX Daily Sw.. 0.00 % 0.00 %

-120.00 (0%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Capital Markets) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.28% 34% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.28% 35% F 61% D-
Trailing 12 Months  
Capital Gain 12.38% 28% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.38% 29% F 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 40.46% 86% B+ 93% A
Dividend Return 308.26% 96% N/A 98% N/A
Total Return 267.80% 95% A 97% N/A
Risk Return Profile  
Volatility (Standard Deviation) 488.64% 4% F 2% F
Risk Adjusted Return 63.09% 75% C 77% C+
Market Capitalization 0.37B 44% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.